Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@BustStock](/creator/twitter/BustStock)
"$SRPT Me every fukin time read the data"  
[X Link](https://x.com/BustStock/status/1975608167741702472) [@BustStock](/creator/x/BustStock) 2025-10-07T17:04Z XX followers, 2176 engagements


"$SRPT The new SRP-9003 update confirms what bulls expected: Robust durable -sarcoglycan expression better muscle function manageable safety. Phase X underway BLA coming next. Combine that with Sareptas siRNA lineup (10011004) and this name is looking stacked for 2026+"  
[X Link](https://x.com/BustStock/status/1978475450222387302) [@BustStock](/creator/x/BustStock) 2025-10-15T14:58Z XX followers, 1721 engagements


"$SRPT massively undervalued even after a XX% move. They are already generating over $1.7B in revenue and guiding for $2.32.6B this year. Elevidys is scaling faster than expected SRP9003 just cleared its Phase III endpoint and the FDA tone has turned more constructive since WMS"  
[X Link](https://x.com/BustStock/status/1979619291197493517) [@BustStock](/creator/x/BustStock) 2025-10-18T18:43Z XX followers, 1085 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BustStock "$SRPT Me every fukin time read the data"
X Link @BustStock 2025-10-07T17:04Z XX followers, 2176 engagements

"$SRPT The new SRP-9003 update confirms what bulls expected: Robust durable -sarcoglycan expression better muscle function manageable safety. Phase X underway BLA coming next. Combine that with Sareptas siRNA lineup (10011004) and this name is looking stacked for 2026+"
X Link @BustStock 2025-10-15T14:58Z XX followers, 1721 engagements

"$SRPT massively undervalued even after a XX% move. They are already generating over $1.7B in revenue and guiding for $2.32.6B this year. Elevidys is scaling faster than expected SRP9003 just cleared its Phase III endpoint and the FDA tone has turned more constructive since WMS"
X Link @BustStock 2025-10-18T18:43Z XX followers, 1085 engagements

creator/twitter::1457598643041603588/posts
/creator/twitter::1457598643041603588/posts